Evidence map›Paper›PMID 21442427›Full record

ArticleCellular and molecular life sciences : CMLS2011

Cdk5 targets active Src for ubiquitin-dependent degradation by phosphorylating Src(S75).

Q Pan, F Qiao, C Gao, B Norman, L Optican, Peggy S Zelenka

Open access · greenAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Regulation, targets and functions of CHK.Frontiers in cell and developmental biology · 2022
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Q PanLaboratory of Molecular and Developmental Biology, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA.
F Qiao
C Gao
B Norman
L Optican
Peggy S Zelenka
National Eye Institute · USNational Institutes of Health · USOffice of Extramural Research · US

Funding

Neural Control Of GazeZIAEY000302 · NEI · NATIONAL EYE INSTITUTE · PI OPTICAN, LANCE M · 2009 to 2019
$10.2M
Signal transduction in Epithelial Cells of the Lens and CorneaZ01EY000238 · NEI · NATIONAL EYE INSTITUTE · PI ZELENKA, PEGGY S · 1986 to 2008
$4.8M
Signal transduction in Epithelial Cells of the Lens and CorneaZIAEY000238 · NEI · NATIONAL EYE INSTITUTE · PI ZELENKA, PEGGY S · 2009 to 2010
$3.0M
Intramural NIH HHS Z01 EY000238Intramural NIH HHS ZIA EY000238NEI NIH HHS Z01-EY000238-25
6 · The paper itself

Abstract

The non-receptor tyrosine kinase Src is a critical regulator of cytoskeletal contraction, cell adhesion, and migration. In normal cells, Src activity is stringently controlled by Csk-dependent phosphorylation of Src(Y530), and by Cullin-5-dependent ubiquitinylation, which affects active Src(pY419) exclusively, leading to its degradation by the proteosome. Previous work has shown that Src activity is also limited by Cdk5, a proline-directed kinase, which has been shown to phosphorylate Src(S75). Here we show that this phosphorylation promotes the ubiquitin-dependent degradation of Src, thus restricting the availability of active Src. We demonstrate that Src(S75) phosphorylation occurs in vivo in epithelial cells, and like ubiquitinylation, is associated only with active Src. Preventing Cdk5-dependent phosphorylation of Src(S75), by site-specific mutation of S75 or by Cdk5 inhibition or suppression, increases Src(Y419) phosphorylation and kinase activity, resulting in Src-dependent cytoskeletal changes. In transfected cells, ubiquitinylation of Src(S75A) is about 35% that of wild-type Src-V5, and its half-life is approximately 2.5-fold greater. Cdk5 suppression leads to a comparable decrease in the ubiquitinylation of endogenous Src and a similar increase in Src stability. Together, these findings demonstrate that Cdk5-dependent phosphorylation of Src(S75) is a physiologically significant mechanism of regulating intracellular Src activity.

Indexed as

Blotting, WesternCells, CulturedCSK Tyrosine-Protein KinaseCyclin-Dependent Kinase 5Enzyme InhibitorsEpithelial CellsFluorescent Antibody TechniqueHumansImmunoenzyme TechniquesLens, CrystallineMutationPhosphorylationProtein-Tyrosine Kinasessrc-Family KinasesUbiquitinUbiquitinationCDK5 protein, humanCSK protein, humanCSK Tyrosine-Protein KinaseCyclin-Dependent Kinase 5Enzyme InhibitorsProtein-Tyrosine Kinasessrc-Family KinasesUbiquitin

Identifiers

PMID21442427
PMCPMC3167940
OpenAlexW2034935389

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.